312 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial.
https://www.medrxiv.org/content/10.1101/2021.02.11.21249258v1
311 The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
https://www.pnas.org/content/118/6/e2010217118
310 Phylogenetic analysis of complete SARS-CoV-2 genomes provides evidence that superspreading profoundly influenced epidemic spread.
https://science.sciencemag.org/content/371/6529/eabe3261
309 Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
https://www.pnas.org/content/118/5/e2014746118
308 COVID-19 lockdown induces disease-mitigating structural changes in mobility networks.
https://www.pnas.org/content/117/52/32883
307 Face masks considerably reduce COVID-19 cases in Germany.
https://www.pnas.org/content/117/51/32293
306 Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion.
https://www.nature.com/articles/s41564-020-0781-2
305 Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.
https://bmjophth.bmj.com/content/5/1/e000632
304 A probiotic yeast-based immunotherapy against Clostridioides difficile infection.
https://stm.sciencemag.org/content/12/567/eaax4905
303 Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments.
https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1
302 Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
https://www.pnas.org/content/117/41/25897
301 Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
https://www.pnas.org/content/117/41/25237
300 Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
https://www.nature.com/articles/s41586-020-2575-3
299 Hydroxychloroquine is not useful against SARS-CoV-2 infection in non-human primates.
https://www.nature.com/articles/s41586-020-2558-4
298 A network-based explanation of why most COVID-19 infection curves are linear.
https://www.pnas.org/content/117/37/22684
297 The nucleotide analogue prodrug remdesivir reduces viral load and lung disease in a rhesus macaque model of SARS-CoV-2 infection.
https://www.nature.com/articles/s41586-020-2423-5
296 Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
https://science.sciencemag.org/content/369/6508/1210
295 Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
https://science.sciencemag.org/content/369/6508/eabc8511
294 COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis.
https://www.nature.com/articles/s41587-020-0602-4
293 The implications of silent transmission for the control of COVID-19 outbreaks.
https://www.pnas.org/content/117/30/17513
|
